Diligence memo · auto-generated · as of July 2, 2026
Apollo Neuroscience, Inc.
Apollo Neuroscience, Inc. looks under-valued against its niche peers and is quiet on financing cadence.
Businessfiled
Apollo Neuroscience, Inc. operates in Other Health Care, based in PITTSBURGH.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Apollo Neuroscience, Inc. has raised $24M in disclosed capital across 5 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $9.3M on 2023-02-09.
Most recent recorded round closed around 2024-04-15.
Valuation (modeled)modeled
Provath models Apollo Neuroscience, Inc. at approximately $2.6M (range $641K–$5.9M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.07× the median modeled value of Series A Other Health Care companies in 2022–2024 (196 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 8 months.
Last raise 2.2 yr ago; this sector typically re-raises about every 14 months.
Slightly overdue versus sector cadence.
The last round was 12.0× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 86% of Other Health Care peers (5377 compared).
Modeled value ranks above 11% of those peers.
Closest niche peers: CareHarmony, Inc., Dragonfly Endoscopy Inc., NuvoAir Holdings, Inc., Post Acute Recovery, Inc., Micro Interventional Devices, Inc..
Peoplefiled
5 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.